Texas A&M Researchers To Further Develop Unique Cancer Drug With $2.3M NIH Grant
Preliminary data indicate that the compounds developed in the laboratory of Dr. Stephen Safe both kill tumors and rejuvenate the immune system, which becomes exhausted as it responds to cancer. Dr. Stephen Safe is leading a team of researchers from Texas A&M University and Houston Methodist Hospital. A team of Texas A&M University researchers has […]
SHARE